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Abstract
Idiopathic pulmonary fibrosis (IPF) is a deadly disease whose pathology involves
improperly differentiated airway epithelia present in alveolar regions. Previous work from our
group has shown decreased activity of the enzyme glutaredoxin (GLRX) in the lungs of IPF
patients, and demonstrated reversal of lung fibrosis in mice via administration of exogenous
GLRX protein. We modeled airway epithelial tissue using 3D cell culture of wild type and GLRX
-/- airway epithelial basal cells, both in monoculture and in coculture with fibroblasts. We present
data from qPCR and immunohistochemistry which suggest that GLRX is essential for the proper
differentiation of airway epithelia in the presence of fibroblasts. These findings suggest a role for
GLRX in the attenuation of fibrosis via the support of healthy epithelial differentiation.

Introduction
IPF patients have poor clinical prognoses.
Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive disease characterized by the
buildup of scar-like tissue in the lungs, and is one of several diseases falling in the category of
interstitial lung disease1. In the United States, IPF affects between 10 and 60 people per 100,000,
with a disproportionate impact on the elderly1. The most significant symptom of IPF is chronic
exertional dyspnea, or shortness of breath, as the disease stiffens the lung and prevents normal
breathing1. Prognosis for IPF patients is bleak, as the disease tends to progress significantly
during pre-symptomatic and pre-diagnostic periods2. Rates of patient decline are variable, but
median survival time is 2.5-3.5 years post diagnosis2, with FDA-approved drugs Nintedanib and
Pirfenidone capable of slowing, but not resolving IPF3.
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Several genetic variations are known to confer risk for IPF.
Mutations in genes implicated in telomere maintenance, including TERT, TERC, PARN,
and RTEL1 have known associations with increased IPF risk.1 Risk for IPF is also associated with
variation in genes implicated in cell adhesion, integrity, and mechanotransduction, including DSP,
AKAP13, CTNNA, and DPP9.1 Mucin 5B is a protein involved in airway clearance, which is
overexpressed in small airway epithelia in IPF.1 No mechanism linking mucin 5B overexpression
to IPF has been established, but a SNP in the promoter region of the MUC5B gene, which codes
for mucin 5B, predisposes individuals to IPF.1 The microbiome may also play a role in IPF, as
mucin 5B is required for innate immune responses to bacteria, and variation in TOLLIP, a gene
associated with responses to microbes, increases IPF risk.1 GLRX, a gene of interest in this
thesis, has no known association with IPF risk.
Excessive fibroblast activation can lead to fibrosis.
Fibrosis develops when extracellular matrix (ECM) accumulates and disrupts the
physiology of a tissue4. Often, fibrosis occurs in response to repeated tissue insult, where chronic,
unresolved fibroblast activation leads to excessive ECM production and secretion4. Fibroblasts
are a mesenchymal cell type playing a key role in healthy tissues, as well as in the wound repair
process4. Fibroblasts become activated during wound repair in response to intercellular signals
including transforming growth factor β (TGF-β)4. When exposed to TGF-β, fibroblasts upregulate
their production of extracellular matrix (ECM) proteins, such as collagen, and transdifferentiate
into myofibroblasts4. Myofibroblasts are a cell type similar to fibroblasts, which are also involved
in wound healing5. They are distinguished from fibroblasts by expression of the protein α-smooth
muscle actin (α-SMA), lending to more contractile capability than fibroblasts and contributing to
increased tissue stiffness5. Myofibroblasts secrete collagen at a higher rate than fibroblasts and
are known to contribute to the pathology of fibrosis5.
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In IPF, myofibroblasts secrete unorganized but dense collagen into the lung interstitium6.
They adhere to ECM and irreversibly contract, increasing tissue stiffness6. This stiffening process
is subject to positive feedback, as myofibroblast ECM synthesis itself is upregulated by contact
with stiffer ECM6. A key distinguishing histological feature of the IPF lung is the presence of
fibroblastic foci6. These are regions of lung tissue characterized by clustered fibroblasts and
myofibroblasts adjacent to epithelia, and serve as sites of massive ECM generation6. Lung fibrosis
impairs normal gas exchange by interfering with alveolar physiology and compromises respiration
by stiffening the lung, leading to eventual patient death6.
Abnormal epithelial differentiation is a key component of IPF pathogenesis.
Many cell types must communicate properly during the development and maintenance of
the lung7. A key step leading to fibroblast activation in the pathogenesis of IPF is aberrant
differentiation of alveolar epithelia7. Single cell RNA sequencing (scRNA-seq) data has shown
disrupted epithelial cell differentiation patterns in IPF7. In addition, scRNA-seq data on IPF lung
epithelia has shown atypical expression of Maternally Expressed Gene 3 (MEG3), which encodes
a long noncoding RNA that is a marker of indeterminate and atypical basal cell phenotypes7.
MEG3 is known to inhibit genes implicated in normal basal cell differentiation. Recent studies
have also reported progenitor-like cells displaying dysregulated differentiation markers present
around myofibroblast foci in the IPF lung7. In keeping with these findings of suppressed epithelial
differentiation in IPF, increased numbers of keratin 5-positive basal cells have been found in the
IPF lung7. These aberrant epithelia secrete a wide variety of intercellular signals, including TGFβ, which can induce fibroblast activation7.
While aberrant epithelia can stimulate fibroblast activation, healthy epithelia can suppress
fibroblast activation8. Bone morphogenic protein (BMP4) is secreted by healthy epithelia and has
been shown to block fibroblast activation using organoid models8. When epithelia are damaged,
BMP4 secretion declines, and fibroblast activation is derepressed8. Exogenous BMP4 has been
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shown to maintain fibroblast repression in organoids with damaged epithelia, and blocking BMP4
signaling has been shown to prevent fibroblast repression in healthy organoids8 (Figure 1).

Figure 1. Key components of currently understood IPF pathology are compared to normal lung signaling. While
healthy epithelia can suppress fibroblast activation via BMP4, aberrant epithelia can stimulate fibroblast activation via
TGF-β and other signaling molecules. Activated fibroblasts lead to fibrosis via transdifferentiation to myofibroblasts and
ECM secretion.

Airway epithelial basal cells differentiate into secretory and ciliated cells.
The origin of aberrantly differentiated epithelial cells in IPF alveoli is not clear, but
migration of more proximal airway epithelia has been proposed as one explanation7. In recent
studies, airway basal cells have been found aberrantly in alveolar regions of IPF lung, suggesting
a role for airway basal cells in IPF pathology9. For this reason, this thesis will focus on proximal
lung epithelia, in order to study the potential contribution of migrated airway epithelial cells to IPF
development in the alveolus.
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The proximal lung epithelium has the function of purifying inhaled air before gas exchange
is to occur in the alveoli10. In this tissue, secretory cells secrete mucus that lines the airway,
trapping inhaled pathogens and toxic materials10. Ciliated cells also populate the epithelium,
flushing mucus in the proximal direction10. Both ciliated and secretory cells are produced by the
differentiation of progenitor basal cells, which maintain the epithelium via proliferation10.
Oxidative stress is implicated in lung fibrosis.
Oxidative stress has been shown to be increased in lung fibrosis, but the mechanism by
which oxidative stress may lead to fibrosis is unclear11. Oxidative stress occurs when reactive
oxygen species (ROS) are produced during oxidative phosphorylation at a higher rate than they
can be scavenged by antioxidants11. ROS are also produced normally via other mechanisms for
the purpose of cellular signaling, and the effects of ROS in aging are complex and context
dependent11. Cell senescence is one key component of tissue aging known to be driven by ROS11,
and senescence of epithelial cells is known to contribute to pulmonary fibrosis6. Mice that are
naturally aged have been shown to be more sensitive to fibrosis induced by environmental stimuli
and injuries than younger mice6. Senescence of aged epithelia likely contributes to IPF
pathogenesis via two mechanisms: firstly, permanent arrest of the cell cycle prevents senescent
cells from performing self-repair or tissue repair upon injury; secondly, senescent cells secrete
cytokines, including TGF-β, which induce fibroblast activation7.
GLRX administration reverses induced lung fibrosis in mice.
Because of the implication of oxidative stress in fibrotic disease, our group is interested in
studying the roles of redox signaling in IPF. Glutathione (GSH) is a tripeptide which is attached to
proteins in order to prevent their oxidation, and plays a key role in cellular redox signaling12.
Protein-S-glutathionylation (PSSG) is the process by which GSH gets covalently attached to
proteins, and may play a role in signaling mechanisms12. GSH is known to be depleted in the
lung-lining fluid of IPF patients12. Glutaredoxin (GLRX) is an enzyme which removes glutathione
7

from proteins, reversing PSSG12. The Janssen-Heininger research group has previously shown
decreased GLRX enzymatic activity in the lungs of human IPF patients and used bleomycininduced pulmonary fibrosis mouse models to study the effects of GLRX protein12. Bleomycin is a
cancer drug known to cause DNA damage and lipid peroxidation, whose toxicity is especially
potent in lung tissue, and leads to the development of fibrosis13. Work with these mouse models
in our lab demonstrated reversal of lung fibrosis via administration of exogenous GLRX protein12.
In the same study, the group also showed that mice lacking GLRX were more susceptible to
bleomycin-induced lung fibrosis, and mice overexpressing GLRX were less susceptible12. These
findings suggest an important role for GLRX during lung fibrosis. It remains unclear whether GLRX
activity important for lung fibrosis occurs intracellularly or extracellularly.
3D culture provides a valuable model for the study of tissue morphogenesis.
Three-dimensional (3D) cell culture allows for the ex-vivo growth of cells in a condition
that better mimics the in-vivo environment than do traditional, 2D culture dishes14. When cultured
in a 3D hydrogel, cells with stem-like properties undergo cell division, differentiation and selforganization, and are capable of reproducing important structures in mammalian anatomy14. This
model system enables researchers to manipulate and closely analyze tissue morphogenesis
without the restrictions of using live animal models, and also shows promise for personalized
medical care14. 3D culture is rising in prominence in the study of lung development and disease.
Organoids have been successfully grown from airway epithelial basal cells (tracheospheres), with
ciliated and secretory cell types present after development15. This model system presents a
powerful tool with which diseases like IPF can be studied.
Hypothesis
In this thesis, I examine the hypothesis that GLRX is essential for normal airway basal cell
differentiation into ciliated or secretory cells. If airway epithelial cells deficient in GLRX display
aberrant differentiation, this could lead to fibroblast activation and ECM secretion in the
8

pathogenesis of IPF, and help to explain our group’s previous findings that GLRX can resolve
bleomycin-induced lung fibrosis in mice.

Methods
GLRX Knockout
A GLRX -/- mouse line was generated using a C57Bl/6J background. This yielded mice
lacking GLRX and containing a NEO cassette. Genotyping was performed for GLRX and NEO
to confirm gene knockout. GLRX knockout conferred no observable developmental lethality, and
GLRX -/- mice survived to adulthood with no observable defects.
Cell culture
Mouse tracheal epithelial cells (mTECs) were isolated from euthanized wild-type or GLRX
-/- mice by removing the tracheas and submerging them overnight at 4 ℃ in OptiMEM with 0.1%
protease type 14. The following day, the tracheas were flushed with DMEM/F12 supplemented
with 10% FBS into a 50 mL tube, centrifuged at 500 x g for 5 minutes at 4 ℃, and the resulting
pellet was resuspended in culture media and placed in T75 flasks pre-coated with 7.5 mL
polymerized rat tail collagen. mTECs were expanded in 2D culture for 14 days, after which the
collagen gel was digested with 400 µg/mL collagenase and cells were freed by incubation with
0.05% trypsin. Cells were then centrifuged at 500 x g for 5 minutes at 4 ℃, resuspended in culture
medium and then centrifuged again. The resulting pellet was resuspended in Pneumacult ALI
medium from Stemcell Technologies (Vancouver, Canada) and used to seed 3D culture
experiments.
Normal human lung fibroblasts (NHLF) were purchased from Lonza Group (Basel,
Switzerland) and expanded in Lonza Fibroblast Growth Medium in T75 flasks. Cells were then
trypsinized, centrifuged at 500 x g for 5 minutes at 4 ℃, resuspended in Pneumacult medium and
used to seed 3D culture experiments.
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For 3D cultures of either mTECs alone or mTECs cocultured with NHLF, each well in 12
well transwell plates was coated with 100 µL 50% GFR Matrigel from Corning Inc. (Corning, NY)
(1:1 volumetrically of Matrigel to Pneumacult medium) and placed in a 37 ℃, 5% CO2 incubator
for 20 minutes to allow hydrogel polymerization. 50,000 mTECs (and in some experiments,
50,000 NHLF) were suspended in 200 µL Pneumacult medium and then combined with 200 µL
Matrigel (resulting in 50% Matrigel) and seeded on top of the polymerized layer of Matrigel in the
well. Cell suspensions were immediately placed in a 37℃, 5% CO2 incubator for 30 minutes to
allow hydrogel polymerization, after which 1 mL Pneumacult medium was added to the lower
chamber. Medium was then changed every 48 hours and cultures were allowed to grow for 28
days.
Immunohistochemistry/Immunofluorescence
Tracheospheres were processed for paraffin embedding by fixing in 4% PFA overnight at
4 ℃, rinsing with PBS and then embedding in Histogel. Histogel-embedded samples were then
fixed in 10% neutral buffered formalin for 4 hours at 4℃, and then placed in 70% ethanol overnight
at 4℃ and then paraffin embedded. Paraffin blocks were then cut into 5µm sections and mounted
on slides for subsequent staining.
For hematoxylin and eosin staining, slides were deparaffinized, rehydrated, incubated in
hematoxylin and eosin, de-stained with tap water, dehydrated and mounted using Permount. For
immunofluorescence staining, slides were deparaffinized, rehydrated, subjected to heat-induced
epitope retrieval and incubated in blocking buffer (10% normal goat serum from Jackson
Immunoresearch Laboratories, West Grove, PA) for 30 minutes at room temperature. After
blocking, slides were incubated with primary antibodies at 4 ℃ overnight, rinsed with PBS and
then incubated with Alexafluor secondary antibodies for 1 hour at room temperature. Slides were
then rinsed with PBS and mounted using Aqua Polymount.
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Imaging
Brightfield imaging was performed on an Olympus IX70 inverted microscope with a Zeiss
AxioCam 202 Mono camera, with images being processed using Zeiss Zen software. Confocal
imaging was performed on a Nikon A1R-ER confocal microscope powered by a LUNV laser
launch and driven by NIS-Elements software.
Antibodies
For immunofluorescence staining, all antibodies were purchased from commercial
vendors and diluted in 5% goat serum blocking buffer. Anti-cytokeratin 5 rabbit antibody ab24647
from Abcam (Cambridge, UK) was used at a dilution of 1:200. Anti-cytokeratin 8 rabbit antibody
ab53280 from Developmental Studies Hybridoma Bank (Iowa City, IA) was used at a dilution of
1:200. Anti-acetylated tubulin mouse antibody T7461 from Sigma-Aldrich (St. Louis, MO) was
used at a dilution of 1:300. Anti-pan-cytokeratin mouse antibody C2562 from Sigma-Aldrich was
used at a dilution of 1:400. Alexafluor 488 and Alexafluor 594 secondary antibodies were
purchased from Thermo Fisher Scientific (Waltham, MA).
RT-qPCR
To obtain RNA from organoids in 3D culture, cells were first separated from the Matrigel
by incubating cultures in Corning Cell Recovery Solution for 20 minutes at 4 ℃, then centrifuged
at 500 x g for two minutes at 4 ℃. Supernatant was removed and pellet was rinsed by
resuspending in ice-cold PBS, then centrifuged at 500xG for 2 minutes 4 ℃. The pellet was again
rinsed with ice-cold PBS, and then resuspended in Qiagen RLT buffer supplemented with 0.01%
β-mercaptoethanol. RNA was then extracted from samples using Qiagen’s RNEasy kit, then
converted to cDNA using MMLV transcriptase. Sample cDNA was then used in SYBR green
(Sigma) qPCR assays using the following primers:
Cytokeratin 5: F: 5’-AGGATGTGGATGCTGCCTAC-3’
R: 5’-CCATGGAAAGGACCACAGAT-3’
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FoxJ1:

F: 5’-CACCCGGCAAGCCCACATCGT-3’
R: 5’-CCTTGCCGGGCTCATCCTTCTC-3’

Scgb1a1:

F: 5’-TGTGGTCATGCTGTCCATCT-3’
R: 5’-GTCTGAGCCAGGGTTGAAAG-3’

GLRX1:

F: 5’-TCAGTCAATTGCCCATCAAA-3’
R: 5’-GCAGAGCTCCAATCTGCTTT-3’

GAPDH:

F: 5’-CAACTCACTCAAGATTGTCAGCAA-3’
R: 5’-TGGAGTGATGGCATCGA-3’

β-actin:

F: 5’-CTGAATGGCCCAGGTCTGA-3’
R: 5’-CCCTCCCAGGGAGACCAA-3’

Mouse-specific binding of primers for Cytokeratin 5, FoxJ1 and Scgb1a1 had previously been
verified (Supplemental Figure 3). CT values were read by the thermocycler via fluorescence of
SYBR green, and were then standardized against GAPDH expression in each culture to produce
DCT values. These were then standardized against the average DCT value for WT in each
condition to produce DDCT values. Fold change was calculated according to the following
equation:
𝐹𝑜𝑙𝑑 𝑐ℎ𝑎𝑛𝑔𝑒 = 2!DD"#

Results
GLRX is not essential for mouse tracheal basal cells to form tracheospheres in 3D
culture.
Research from our group has shown that oropharyngeal administration of GLRX protein
in fibrotic mouse lungs has the effect of reversing existing pulmonary fibrosis. Airway basal cell
gene signatures have recently been observed in alveolar areas of IPF lung, suggesting that basal
cells play a role in IPF pathology. To better understand the roles played by GLRX during the
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morphogenesis and injury repair of lung tissues, we harvested mouse tracheal basal epithelial
cells (mTECs) from both wild type (WT) and GLRX -/- (KO) mice and cultured them in 3D
conditions, which allowed for their differentiation into secretory or ciliated epithelia (Figure 2A).
After 25 days of culture in 3D hydrogel, both WT and GLRX KO mTECs had developed spherical,
fluid-filled organoids (tracheospheres) and light microscopy showed no obvious differences in
organoid appearance between the two conditions (Figure 2B).

Figure 2. WT and GLRX KO mTECs develop spherical organoids in 3D culture. A. Graphical image depicting 3D
cell culture of WT or GLRX KO mTECs. B. Both WT (left panel) and GLRX KO mTEC (right panel) cultures were able
to form fluid-filled organoids when cultured for 25 days in 3D conditions.

Gene expression data obtained via qPCR verified a lack of GLRX expression in the GLRX
KO condition, as compared to WT controls (Figure 3). Additionally, elevated expression of basal
cell marker keratin 5, as well as lowered expression of ciliated cell marker FoxJ1 and secretory
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cell marker Scgb1a1, were found in the GLRX KO condition, as compared to WT, yet these
differences were not statistically significant (Figure 3).

Figure 3. WT and GLRX KO mTEC tracheospheres do not show significantly different differentiation patterns.
While not statistically significant, expression of basal cell marker keratin 5 was slightly higher, while ciliated cell marker
FoxJ1 and secretory cell marker Scgb1a1 were slightly lower in GLRX KO tracheospheres, as compared to WT
tracheospheres. Presence of GLRX in the WT condition and absence in the GLRX KO condition are confirmed. Each
data point represents a biological replicate.

GLRX KO mTECs cocultured with NHLFs in 3D develop a phenotype characterized by
aberrant differentiation and lumenal keratin deposition.
Fibroblasts are a key cell type in the wound healing process, interacting with multiple other
types of cells and secreting ECM to resolve damaged tissues. During IPF, chronic alveolar
epithelial cell injury results in sustained wound healing processes that lead to fibrotic scarring in
the lung. To more closely mimic the in vivo lung environment, we next cocultured WT or GLRX
KO mTECs with normal human lung fibroblasts (NHLF) in 3D conditions (Figure 4A). Markedly
greater differences were seen between the WT and GLRX KO mTECs when they were cocultured
with NHLFs than without them. After 25 days of coculture in 3D hydrogel, both WT and GLRX KO
mTECs had again developed spherical organoids, yet the appearance of the organoids differed
between the two conditions. Light microscopy showed a normal translucent phenotype in
organoids grown from WT mTECs with NHLFs, while organoids grown from GLRX KO mTECs
with NHLFs were abnormal in appearance and did not permit light to pass through (Figure 4B).
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Figure 4. Tracheospheres from GLRX KO mTECs display abnormal morphogenesis when cocultured with
NHLFs. A. Graphical image depicting 3D cell coculture of NHLF with WT or GLRX KO mTECs. B. WT mTECs
cocultured with NHLFs form spherical organoids after 25 days of development in 3D culture, while GLRX KO mTECs
cocultured with NHLFs form abnormal structures that are too dense for light to penetrate.

Using qPCR with species-specific primers (as mTECs came from mouse tissue and
NHLFs came from human tissue), GLRX expression was again validated in the WT mTECs, while
no expression was found in the GLRX KO mTECs. Basal cell marker keratin 5 was significantly
higher, while ciliated cell marker FoxJ1 was significantly lower, in GLRX KO mTECs cocultured
with NHLFs, as compared to WT mTECs with NHLFs (Figure 5). Secretory cell marker Scgb1a1
was elevated in the GLRX KO condition, but this result was not significant (Figure 5).
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Figure 5. GLRX KO mTEC + NHLF tracheospheres display suppressed differentiation compared to WT mTEC
+ NHLF tracheospheres. Basal cell type marker keratin 5 was elevated in the GLRX KO condition. Ciliated cell type
marker FoxJ1 was lowered in the GLRX KO condition. Secretory cell type marker Scgb1a1 was not significantly different
in the two conditions. Presence of GLRX in the WT condition and absence in the GLRX KO condition are confirmed.
Each data point represents a biological replicate.

The aberrant phenotype seen in organoids grown from GLRX KO mTECs with NHLFs
suggested a critical role for GLRX in the differentiation of basal cells in the presence of fibroblasts
found in the lung. To further understand this differentiation defect, we next used hematoxylin and
eosin staining on the organoids grown from mTECs and NHLFs, which showed a high frequency
of protein buildup in the interior lumenal space of organoids from GLRX KO mTECs, as compared
to WT (Figure 6A). Immunofluorescence staining showed a lack of a lumenal, differentiated cell
layer lining the inner side of the organoid epithelium in the GLRX KO condition, with both lumenal
cell marker cytokeratin 8 (Figure 6B) and ciliated cell marker acetylated tubulin (Figure 7A) absent
in most GLRX KO mTEC + NHLF organoids.
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Figure 6. When cocultured with NHLFs, GLRX KO mTEC organoids show aberrant development. A phenotype
characterized by protein buildup in the organoid interior was present with high frequency in the GLRX KO condition (A).
Lumenal cell marker cytokeratin 8 (CK8) was largely absent from organoids with in the GLRX KO condition. Basal
marker cytokeratin 5 (CK5) was present around the exterior of all organoids (B).

Quantification of the organoids showed a significant difference in acetylated tubulin
expression (Figure 7B). While the protein buildup did not stain positive for keratin 5 or 8, a pancytokeratin staining showed the presence of high levels of keratin in the protein buildup in the
aberrantly developed organoids, now dubbed “keratin bodies” (Figure 8A). When cultured in the
presence of human lung fibroblasts, GLRX KO mTEC organoids had a significantly higher
frequency of keratin bodies than did WT mTEC organoids. Organoids grown from GLRX KO
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mTECs + NHLFs also had a significantly higher frequency of keratin bodies than organoids grown
from either WT or GLRX KO mTECs alone. Coculture with NHLFs did not, however, produce a
higher frequency of keratin bodies in WT mTEC organoids (Figure 8B).
Collectively, these results demonstrate the importance of GLRX during basal cell
differentiation and tracheosphere morphogenesis in the presence of lung fibroblasts, and suggest
a key role for GLRX in epithelial-fibroblast crosstalk during wound repair.

Figure 7. When cocultured with NHLFs, GLRX KO mTEC organoids lack a ciliated cell layer significantly more
frequently than WT mTEC organoids. A. Immunofluorescence staining depicting ciliated cell marker acetylated
tubulin largely absent from organoids in the GLRX KO mTEC + NHLF condition, as compared to WT controls. Basal
cell marker cytokeratin 5 (CK5) was present around the exterior of all organoids. B. Quantification of mTEC organoids
grown in the presence of NHLFs showing that the presence of acetylated tubulin was significantly less frequently found
in the GLRX KO mTEC condition than the WT mTEC condition. Data were not available for the GLRX KO mTEC
monoculture condition due to damage to samples during antibody staining. Each data point represents a biological
replicate.
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Figure 8. Keratin(s) comprise the protein buildup found in lumens of GLRX KO mTEC + NHLF organoids. A.
Immunofluorescence imaging of pan-cytokeratin showing cytokeratin protein buildup in the lumenal spaces of the
aberrant GLRX KO mTEC + NHLF organoids. B. Both GLRX KO and NHLF coculture conditions increase the frequency
of these keratin bodies. Among organoids grown from mTECs alone, GLRX KO organoids had a significantly higher
frequency of keratin bodies than did WT organoids. Among GLRX KO mTEC organoids, those grown from mTECs +
NHLFs had a significantly higher frequency of keratin bodies than did those grown from mTECs alone. Each data point
represents a biological replicate.

Discussion
Role of GLRX in normal airway basal cell differentiation
Previous studies have demonstrated airway epithelial cells abnormally populating alveolar
regions of the lung in IPF patients9. Additionally, research from our group has shown that GLRX
can reverse induced pulmonary fibrosis in mice12. In this study, we set out to identify the roles of
GLRX in airway basal cells by isolating them from WT or GLRX KO mice and culturing them in
3D conditions that would allow for proper differentiation. Interestingly, GLRX was not, as we
hypothesized, essential for normal differentiation into ciliated or secretory cells. GLRX KO mTECs
grew organoids without significant difference in appearance from WT mTEC organoids (Figure
2), and expressed basal, ciliated and secretory cell markers at levels not significantly different
19

from WT mTEC organoids (Figure 3). However, as epithelia work in concert with other cell types
during in vivo lung development, maintenance and disease, we next proposed that GLRX played
a role in mTEC function in the presence of fibroblasts. To address this, we 3D cocultured mTECs
with commercially-obtained normal human lung fibroblasts. Using this model, GLRX indeed
appeared to be essential for the proper differentiation of airway basal cells into ciliated and
secretory cells. When grown with NHLFs, GLRX KO mTEC organoids displayed a dense
morphology (Figure 4), and failed to display normal differentiation into the normal, lumenal ciliated
and secretory cell types, as shown via qPCR data (Figure 5) and immunofluorescence data
(Figures 6B and 7).
The process of removing mTECs from the mouse and seeding them in 3D culture is similar
to wounding, where normal tissue architecture is interrupted, and the basal cells are left to reform
functional structures. While the mechanisms through which GLRX supports proper basal cell
differentiation are by no means clear yet, these data suggest that the signals provided by
fibroblasts are abnormally received in GLRX KO mTECs. It is quite plausible that GLRX could
alter signaling from fibroblasts to epithelia. For example, by reversing PSSG, GLRX liberates GSH
molecules. So, if fibroblasts are placing epithelia under oxidative stress, increased cytosolic GSH
levels due to GLRX activity could neutralize oxidants, protecting normal epithelial physiology. The
idea that GSH is depleted in IPF is not new, as lower levels of GSH in fluid of the lung lining has
been reported in IPF patients12. In addition to being an important antioxidant, GSH is also an
important signaling molecule16. GLRX could therefore alter signaling from fibroblasts to airway
basal cells either by liberating GSH to bind signaling proteins, or by deglutathionylating signaling
proteins.
Significance of lumenal keratin in tracheospheres
The keratin body tracheosphere phenotype observed in our experiments (Figures 6A, 8A)
is dramatic in the degree to which the lumenal space is filled with keratin protein. If a pulmonary
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airway were similarly filled with keratin, massive airflow blockage would occur, and respiration
would be inhibited. However, a real human airway would be unlikely to become obstructed in this
way, due to the constant flow of gas through the region, as well as the constant removal of waste
via cilia beating. In the alveoli, however, blockage by keratin is conceivable, given their nearspherical shape and lack of ciliated cells. Obstruction of gas exchange in the lung is a known
cause of respiratory failure, as seen in chronic obstructive pulmonary disease (COPD)17, but so
far IPF research has provided little documentation of this kind of airway obstruction. Ultimately,
our keratin body finding is most likely significant as a clue about the aberrant epithelia which are
secreting keratin, rather than as a model of pathology in IPF.
Implications for IPF pathology
It is well established in the literature that aberrant epithelial differentiation plays a key role
in the development of IPF7. In addition, recent work has shown that airway basal epithelial cells
are aberrantly located in alveolar regions of the IPF lung9. Here, we present evidence that, in
GLRX-deficient airway basal cells, the presence of fibroblasts leads to improper differentiation in
3D culture. Taken together with previous research showing airway cells abnormally located in
alveolar regions of the IPF lung7, and research showing that GLRX deficiency is implicated in
IPF12, our data add novel insight into the roles of GLRX in airway basal cell differentiation in IPF
(Figure 9). Reasons for airway epithelial cell migration to the alveoli remain unknown, as do the
specifics of how GLRX affects signaling from fibroblasts to airway basal cells. Our findings
suggest, however, that airway basal cells rely on GLRX for their proper differentiation in the
presence of lung fibroblasts and, given that GLRX expression is lowered in IPF, raise interesting
questions about the status of GLRX expression in human IPF basal cells.
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Figure 9. Fibroblasts suppress differentiation of GLRX-deficient epithelial basal cells. In our experiments, mTECs
required GLRX to differentiate properly into ciliated and secretory epithelial cell types when cocultured with NHLFs.
This, together with findings that aberrant epithelial differentiation plays a role in IPF pathology, and findings that GLRX
is deficient in IPF, suggests that suppression of GLRX-deficient epithelial cell differentiation by fibroblasts plays a role
in IPF pathology.

Future Directions
Further analysis of present 3D culture models
Understanding the mechanism through which differentiation was altered in the GLRX KO
mTECs cocultured with NHLF will depend on a more detailed picture of gene expression. It is
not obvious why the GLRX KO mTECs would be producing so much excess keratin, but a first
step will be determining which keratin protein is secreted. To do this, we will be performing
mass spectrometry on laser-microdissected keratin bodies from slides of the cocultures of
GLRX KO mTECs and NHLF. Once the keratin body composition is characterized, a future
experiment may use qPCR or SDS-PAGE/Western blot to examine the expression of the
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particular keratin gene at different timepoints during tracheosphere development. It will also be
important to explore links between the transcriptional regulation of genes required for production
and secretion of this keratin protein, and genes required for differentiation to ciliated and
secretory cell types.
In order to further examine the effects of GLRX in our 3D culture model system, we will
be performing immunohistochemical stains for PSSG on our samples. By comparing our
conditions, we will aim to examine where in our organoids GLRX is impacting PSSG levels, and
how this is altered by the presence of fibroblasts.
Our analysis of qPCR data to determine expression of cell type markers relied on
comparison to the expression of glyceraldehyde-3-phosphate dehydrogenase (GAPDH).
GAPDH has traditionally been used as a control gene for RT-PCR, as it is expressed in all cells.
Recent work, however, has shown that GAPDH expression levels can vary significantly in
different tissues.18 In the past decade, research has identified a list of genes, including glucose6-phosphate isomerase (GPI), whose expression levels are especially constant across tissues
and conditions.18 If we ran our qPCR experiments again, using GPI as a housekeeping gene
instead of GAPDH, we may obtain more accurate measures of gene expression for our genes of
interest.
Our qPCR and immunohistochemistry data gave an indication of how cells had
differentiated in our organoids, but only provided information on the expression of a few genes.
Spatial transcriptomic data would provide a more complete picture of organoid development in
our 3D culture conditions. A variety of spatial transcriptomic approaches exist, with the common
aim of obtaining data on the expression of different genes in different regions of a tissue
sample.19 These approaches generally involve imaging a tissue sample, assigning a barcode to
a tissue region or even a single cell, and performing RNA sequencing on individual regions or
cells from the sample.19 Performing such experiments would allow us to identify a wide variety
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of changes in gene expression in GLRX KO mTEC + NHLF organoids, beyond a single cell type
marker.
Effects of fibroblast activation on suppression of epithelial differentiation
Having shown that NHLFs suppress GLRX KO mTEC differentiation, we will next examine
how fibroblast activity modulates this effect. Future experiments may include mTECs cocultured
with NHLFs of varying concentrations, NHLFs that have been incubated in TGF-β, and NHLFs
that have been incubated in BMP4. We will aim to determine whether myofibroblast
transdifferentiation or ECM secretion are important to the differentiation-suppressing effect
NHLFs displayed towards GLRX KO mTECs. Fibroblast activation could upregulate a signaling
mechanism that leads to the effects seen in our experiments, or it could simply lead to fibroblast
proliferation and resultant increase in fibroblast number. Either way, a causal link between NHLF
activation and the suppression of GLRX KO mTEC differentiation could have major implications
for our understanding of IPF.
Effects of mTECs on fibroblast activation
It has been shown that healthy epithelia suppress fibroblast activation8, and that aberrant
epithelia induce fibroblast activation7, yet we do not know whether these effects are present in
our 3D cocultures of NHLFs with WT and GLRX KO mTECs. In the future we will analyze the
expression of α-SMA to determine whether the WT and GLRX KO mTECs differ in their ability to
suppress myofibroblast activation. Data on α-SMA expression will be specific to NHLFs and their
progeny, as we cocultured cell types from different species, (mTECs from mice and NHLFs from
humans). These data, along with data from cocultures of WT and GLRX KO mTECs with TGF-βand BMP4-incubated NHLFs will allow us to develop more informed hypotheses about the nature
of epithelium-fibroblast crosstalk in our organoids and in IPF.
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Hypothesized positive feedback mechanism
A hypothesis that I find quite intriguing is that the activation of NHLFs by aberrant mTECs
and the suppression of mTEC differentiation by active NHLFs could act in a mutually reinforcing
manner. Validation of this hypothesis will depend on the results of the experiments suggested
above, but could uncover a potent positive feedback mechanism driving IPF (Supplemental Figure
1). In this hypothetical mechanistic model, GLRX-deficient epithelium is present in the damaged
alveolar region of IPF lung, possibly as a result of epithelial cell migration from the airway as
described above. Signaling from fibroblasts in the alveolus suppresses differentiation of this
epithelium, yielding aberrant epithelium. This aberrant epithelium then activates those fibroblasts
via TGF-β and other signaling molecules, thereby increasing the suppression of epithelial
differentiation. As fibroblasts become increasingly activated, they transdifferentiate into
myofibroblasts, which secrete large amounts of ECM stiffening the lung tissue and disrupting
alveolar gas exchange. This model could explain the ability of GLRX to resolve bleomycin induced
lung fibrosis in mouse models, as blocking the differentiation-suppressive signal from fibroblasts
to epithelia could halt the mechanism of fibrosis generation.
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Supplemental Figure 1. A hypothesized model of positive feedback between aberrant epithelial differentiation
and fibroblast activation. In this model, aberrant epithelium fails to block fibroblast activation via BMP and other
signaling molecules, and instead activates fibroblasts via TGF-β and other signaling molecules. Activated fibroblasts
transdifferentiate into myofibroblasts and secrete ECM, producing fibrosis. They also suppress epithelial differentiation
in the absence of GLRX, producing more aberrant epithelium.

Conditional Knockout of GLRX
In order to more accurately identify the roles of GLRX during mTEC differentiation, our lab
has also generated a tamoxifen inducible GLRX conditional deletion mouse line. We recently
performed 3D culture of mTECs which had LoxP sites inserted around the GLRX gene, and a Cre
recombinase gene inducible by the drug tamoxifen via the keratin 5 promoter sequence. We grew
these cultures in 3D with tamoxifen doses of 0nM, 100nM, 250nM, and 500nM. Interestingly,
despite confirming GLRX knockout with all non-zero tamoxifen doses, only the 500nM dose
produced an increase in basal cell marker keratin 5 (Supplemental Figure 2). It is suspected that
this may be due not only to the absence of GLRX, but to the presence of high levels of tamoxifen
itself, or possibly Cre recombinase. In order to control for the effects of tamoxifen and isolate the
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effects of GLRX, we will repeat the experiment, this time using two additional mTEC cell lines.
The first will be normal mTECs, and the second will express Cre recombinase in response to
tamoxifen, but will not have any LoxP sites around its GLRX gene. These three experiments run
in parallel will allow us to separate the effects of tamoxifen, Cre recombinase, and GLRX
expression. In addition to verifying knockout of GLRX via qPCR, we will also run western blots for
organoids at different time points during development, in order to determine how long glutaredoxin
protein remains present in the cell after tamoxifen in introduced. If successful, this model system
will allow us to examine the effects of GLRX knockout in mTECs, independent of any departures
from the wild type phenotype that occur as a result of GLRX absence during mouse development.

Supplemental Figure 2. Tamoxifen-induced conditional knockout of GLRX increases expression of basal cell
marker keratin 5 (K5) at a dosage of 500 nM. In mTEC organoids, expression of basal marker keratin 5 was increased
at 500 nM compared to other doses. Expression of mitotic marker Ki67 was not significantly different at increasing
tamoxifen doses. GLRX presence is shown with 0 nM tamoxifen and absence is shown at 100, 250 and 500 nM.
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Appendix

Supplemental Figure 3. Primers for keratin 5 (K5), FoxJ1 and Scgb1a1 do not amplify cDNA from NHLFs. cDNA
quantity fold change for keratin 5, FoxJ1 and Scgb1a1, using amplification primers specific to mouse genes, is shown
for WT mTEC + NHLF cocultures alongside NHLF monocultures.
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